PATENT CLAIM ANALYSIS

Application Number: 15980668
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "224800"]

Abstract:
This invention provides methods of identifying agents useful to prevent, ameliorate or treat one or more symptoms of Friedreich's ataxia or other neurodegenerative disease, and methods of employing the identified agents to prevent, reduce, delay or inhibit one or more symptoms of Friedreich's ataxia or other neurodegenerative disease.

Claim (Index 54):
A method of increasing frataxin expression in a cell comprising contacting the cells with an agent, which comprises dimethyl fumarate or a derivative thereof metabolizable from dimethyl fumarate under physiological conditions, wherein expression of frataxin is increased.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.77419
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15472852', '13514288', '14862072', '14480899', '15568961']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7546208153712389
- 35 USC 102 Novelty (BERT): 0.5167565988939175
- Combined Prediction Score: 0.7308343937235068
- Mean Citation Score: 268.99516600000004
- Max Citation Score: 302.3657
- Similarity Product: 208.20994128700488

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test